Pharmaceutical Technology

JUNE 25, 2025

Medera and its subsidiary Novoheart have collaborated with scientists at the University of California San Diego School of Medicine and Mayo Clinic to develop mini-heart models for hypoplastic left heart syndrome (HLHS). Credit: shisu_ka/Shutterstock. Don’t let policy changes catch you off guard.

Mayo Clinic 52

Mayo Clinic Packaging Communication Hospitals 52

Pharmacy Times

JUNE 23, 2025

CMS is issuing unique J-codes for 505(b)(2) drugs, classifying them as sole-source products if not therapeutically equivalent. This pathway reduces submission denial risk, accelerates drug development, and offers potential market exclusivity for up to 7 years.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Putting Patients First Blog

APRIL 30, 2024

Mayo Clinic Proceedings, 96(8) , 2095-2101. A blueprint for developing patient-centered core impact sets (PC-CIS). Re: Patient-Focused Drug Development: Collecting Comprehensive and Representative Input; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders (Docket No.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

STAT

NOVEMBER 19, 2024

Jupiter has raised $70 million from investors including Mission BioCapital and the Mayo Clinic to start small biotechs that might eventually be sold off at much higher valuations.

Mayo Clinic 352

Mayo Clinic Drug Development 352